4/A

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: April 24, 2017
Period of Report: April 18, 2017
Accession Number: 0001645627-17-000039

View Document ↗ View on SEC.gov ↗